Author:
Eriksson A,Österroos A,Hassan S,Gullbo J,Rickardson L,Jarvius M,Nygren P,Fryknäs M,Höglund M,Larsson R
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Hurle MR, Yang L, Xie Q, Rajpal DK, Sanseau P, Agarwal P . Computational drug repositioning: from data to therapeutics. Clin Pharmacol Ther 2013; 93: 335–341.
2. Laubenbacher R, Hower V, Jarrah A, Torti SV, Shulaev V, Mendes P et al. A systems biology view of cancer. Biochim Biophys Acta 2009; 1796: 129–139.
3. Fox S, Farr-Jones S, Sopchak L, Boggs A, Nicely HW, Khoury R et al. High-throughput screening: update on practices and success. J Biomol Screen 2006; 11: 864–869.
4. Hart CP . Finding the target after screening the phenotype. Drug Discov Today 2005; 10: 513–519.
5. Dhar S GJ, Nilsson K, Nygren P, Larsson R . A nonclonogenic cytotoxicity assay using primary cultures of patient tumor cells for anticancer drug screening. J Biomol Screen 1998; 3: 207–216.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献